Stay updated on Empagliflozin in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the study is now listed as No longer looking for participants. The Intervention section label was updated from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision note was updated to Revision: v3.6.0 (removing v3.5.5).SummaryDifference0.5%

- Check19 days agoChange DetectedThe page now displays a new revision number, updating the platform version from v3.5.4 to v3.5.5. This change is administrative and does not alter the study details shown.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s metadata and not altering the study details or content. No data or content changes are evident.SummaryDifference0.1%

- Check62 days agoChange DetectedThe ClinicalTrials.gov page footer version was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the study information shown.SummaryDifference0.1%

- Check70 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page now shows a new system revision label 'Revision: v3.5.0' and the previous 'Revision: v3.4.3' entry has been removed.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.